- Home
- CRBU vs ANIK Comparison
CRBU vs ANIK Comparison
Compare CRBU & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- ANIK
- Stock Information
- Founded
- CRBU 2011
- ANIK 1983
- Country
- CRBU United States
- ANIK United States
- Employees
- CRBU N/A
- ANIK N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- ANIK Medical/Dental Instruments
- Sector
- CRBU Health Care
- ANIK Health Care
- Exchange
- CRBU Nasdaq
- ANIK Nasdaq
- Market Cap
- CRBU 188.8M
- ANIK 157.8M
- IPO Year
- CRBU 2021
- ANIK 1993
- Fundamental
- Price
- CRBU $1.90
- ANIK $8.25
- Analyst Decision
- CRBU Strong Buy
- ANIK Buy
- Analyst Count
- CRBU 4
- ANIK 1
- Target Price
- CRBU $8.50
- ANIK $15.00
- AVG Volume (30 Days)
- CRBU 1.8M
- ANIK 159.8K
- Earning Date
- CRBU 08-12-2025
- ANIK 07-30-2025
- Dividend Yield
- CRBU N/A
- ANIK N/A
- EPS Growth
- CRBU N/A
- ANIK N/A
- EPS
- CRBU N/A
- ANIK N/A
- Revenue
- CRBU $9,918,000.00
- ANIK $114,548,000.00
- Revenue This Year
- CRBU $9.52
- ANIK N/A
- Revenue Next Year
- CRBU N/A
- ANIK $9.70
- P/E Ratio
- CRBU N/A
- ANIK N/A
- Revenue Growth
- CRBU N/A
- ANIK 16.52
- 52 Week Low
- CRBU $0.66
- ANIK $7.87
- 52 Week High
- CRBU $3.00
- ANIK $27.00
- Technical
- Relative Strength Index (RSI)
- CRBU 53.41
- ANIK 31.33
- Support Level
- CRBU $1.86
- ANIK $7.87
- Resistance Level
- CRBU $2.13
- ANIK $8.82
- Average True Range (ATR)
- CRBU 0.22
- ANIK 0.65
- MACD
- CRBU -0.05
- ANIK -0.28
- Stochastic Oscillator
- CRBU 15.76
- ANIK 10.16
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.